These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 11276765)

  • 1. Hyperglycemia, glycoxidation and receptor for advanced glycation endproducts: potential mechanisms underlying diabetic complications, including diabetes-associated periodontitis.
    Lalla E; Lamster IB; Drury S; Fu C; Schmidt AM
    Periodontol 2000; 2000 Jun; 23():50-62. PubMed ID: 11276765
    [No Abstract]   [Full Text] [Related]  

  • 2. Advanced glycation endproducts (AGEs) induce oxidant stress in the gingiva: a potential mechanism underlying accelerated periodontal disease associated with diabetes.
    Schmidt AM; Weidman E; Lalla E; Yan SD; Hori O; Cao R; Brett JG; Lamster IB
    J Periodontal Res; 1996 Oct; 31(7):508-15. PubMed ID: 8915955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advanced glycation endproducts in diabetes and diabetic complications.
    Vlassara H; Striker GE
    Endocrinol Metab Clin North Am; 2013 Dec; 42(4):697-719. PubMed ID: 24286947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Receptor for advanced glycation endproducts (RAGE) and the complications of diabetes.
    Stern DM; Yan SD; Yan SF; Schmidt AM
    Ageing Res Rev; 2002 Feb; 1(1):1-15. PubMed ID: 12039445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diabetes mellitus, oxidative stress and advanced glycation endproducts].
    Bonnefont-Rousselot D; Beaudeux JL; Thérond P; Peynet J; Legrand A; Delattre J
    Ann Pharm Fr; 2004 May; 62(3):147-57. PubMed ID: 15243348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advanced glycation end products: a link between periodontitis and diabetes mellitus?
    Gurav AN
    Curr Diabetes Rev; 2013 Sep; 9(5):355-61. PubMed ID: 23845077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycation as the glucose link to diabetic complications.
    Gugliucci A
    J Am Osteopath Assoc; 2000 Oct; 100(10):621-34. PubMed ID: 11105451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis.
    Schmidt AM; Yan SD; Wautier JL; Stern D
    Circ Res; 1999 Mar; 84(5):489-97. PubMed ID: 10082470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiogenesis impairment by the NADPH oxidase-triggered oxidative stress at the bone-implant interface: Critical mechanisms and therapeutic targets for implant failure under hyperglycemic conditions in diabetes.
    Hu XF; Wang L; Xiang G; Lei W; Feng YF
    Acta Biomater; 2018 Jun; 73():470-487. PubMed ID: 29649637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blockade of receptor for advanced glycation endproducts: a new target for therapeutic intervention in diabetic complications and inflammatory disorders.
    Hudson BI; Bucciarelli LG; Wendt T; Sakaguchi T; Lalla E; Qu W; Lu Y; Lee L; Stern DM; Naka Y; Ramasamy R; Yan SD; Yan SF; D'Agati V; Schmidt AM
    Arch Biochem Biophys; 2003 Nov; 419(1):80-8. PubMed ID: 14568011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advanced Glycation End Products: Potential Mechanism and Therapeutic Target in Cardiovascular Complications under Diabetes.
    Yang P; Feng J; Peng Q; Liu X; Fan Z
    Oxid Med Cell Longev; 2019; 2019():9570616. PubMed ID: 31885827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What's the RAGE? The receptor for advanced glycation end products (RAGE) and the dark side of glucose.
    Yan SD; Stern D; Schmidt AM
    Eur J Clin Invest; 1997 Mar; 27(3):179-81. PubMed ID: 9088851
    [No Abstract]   [Full Text] [Related]  

  • 13. Lilly Lecture 1993. Glycation and diabetic complications.
    Brownlee M
    Diabetes; 1994 Jun; 43(6):836-41. PubMed ID: 8194672
    [No Abstract]   [Full Text] [Related]  

  • 14. Recent progress in advanced glycation end products and diabetic complications.
    Vlassara H
    Diabetes; 1997 Sep; 46 Suppl 2():S19-25. PubMed ID: 9285494
    [No Abstract]   [Full Text] [Related]  

  • 15. Advanced glycation endproducts and their receptor: do they play a role in diabetic cardiomyopathy?
    Arai M
    J Mol Cell Cardiol; 2002 Oct; 34(10):1305-8. PubMed ID: 12392990
    [No Abstract]   [Full Text] [Related]  

  • 16. Pathogenesis of diabetic nephropathy: a radical approach.
    Salahudeen AK; Kanji V; Reckelhoff JF; Schmidt AM
    Nephrol Dial Transplant; 1997 Apr; 12(4):664-8. PubMed ID: 9140991
    [No Abstract]   [Full Text] [Related]  

  • 17. [Oxidative stress in diabetes].
    Mizuta M
    Nihon Yakurigaku Zasshi; 2005 Mar; 125(3):125-8. PubMed ID: 15855729
    [No Abstract]   [Full Text] [Related]  

  • 18. Advanced glycation end products and insulin resistance.
    Unoki H; Yamagishi S
    Curr Pharm Des; 2008; 14(10):987-9. PubMed ID: 18473850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Roles of the receptor for advanced glycation endproducts in diabetes-induced vascular injury.
    Yonekura H; Yamamoto Y; Sakurai S; Watanabe T; Yamamoto H
    J Pharmacol Sci; 2005 Mar; 97(3):305-11. PubMed ID: 15750291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of advanced glycation end products in diabetic neuropathy.
    Sugimoto K; Yasujima M; Yagihashi S
    Curr Pharm Des; 2008; 14(10):953-61. PubMed ID: 18473845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.